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CASE REPORT
USEFULNESS OF kDNA PCR IN THE DIAGNOSIS OF VISCERAL LEISHMANIASIS  
REACTIVATION IN CO-INFECTED PATIENTS
Antonio Carlos NICODEMO(1), Valdir Sabbaga AMATO(1,2), Felipe Francisco TUON(3), Regina Maia de SOUZA(2),  
Thelma Suely OKAY(4) & Lúcia Maria Almeida BRAZ(2)
SUMMARY
It is important to develop new methods for diagnosing relapses in the co-infection of visceral leishmaniasis (VL) and HIV to 
enable earlier detection using less invasive methods. We report a case of a co-infected patient who had relapses after VL treatment, 
where the qualitative kDNA PCR showed a good performance. The kDNA PCR seems to be a useful tool for diagnosing VL and may 
be a good marker for predicting VL relapses after treatment of co-infected patients with clinical symptoms of the disease.
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INTRODUCTION
Visceral leishmaniasis(VL) is a vector-borne disease caused by the L. 
donovani complex (L. donovani and L. infantum or its syn. L. chagasi). It 
currently affects around 12 million individuals in 88 countries, although 
more than 90% of the global VL cases occur in only six countries, 
namely India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil1,9. 
In Brazil the disease has expanded following a process of rural-to-urban-
transmission, and this urbanization has paralleled ruralization of the HIV 
infection. The VL/HIV co-infection has emerged as a serious disease 
pattern with a reduction in therapeutic response and a high relapse rate2. 
Both pathogens have the same target cell (macrophage), thus worsening 
the outcome of both diseases. Therefore, it is essential to improve and 
make diagnostic techniques available, including molecular tools, which 
could replace invasive techniques. 
Laboratory diagnosis can be reached by serological techniques, such 
as indirect immunofluorescence [IFI], enzyme-linked immunosorbent 
assay [ELISA], or immunochromatography [IC]. The diagnosis can also 
be performed by demonstration of amastigotes in stained bone marrow 
aspirate which has a sensitivity of 58%-85% and even by culture in 
Novy-MacNeal - Nicolle [NNN]/BHI medium; the latter can additionally 
improve sensitivity10 and molecular tests such as kDNA PCR. Serological 
tests have limited sensitivity and, as a general rule, should not be used to 
exclude the diagnosis of VL in HIV-infected patients3. The microscopic 
examination requires an invasive procedure and is extremely subjective 
and time consuming. Culture has low sensitivity and takes from one to 
four weeks to give results. Molecular techniques, such as kDNA PCR, in 
which preserved sequences in Leishmania kinetoplast mini-circle DNA 
are amplified, have shown promise6,11. Even when they only allow for 
diagnosis of the genus, it is possible to diagnose recurrence early since 
the molecular method can produce a positive result for VL/HIV several 
weeks before the clinical onset of disease2. Consequently, the tests based 
on DNA detection in peripheral blood (PB) or in bone marrow (BM) 
aspirates can provide an important approach to the diagnosis of VL 
reactivation in co-infected VL/HIV patients.
METHODS
PCR kDNA Methodology
DNA extraction: The DNA from PB and BM samples collected 
with EDTA anticoagulant was extracted according to the manufacturer’s 
protocol of the RBC (Real Biotech Corporation) Genomic DNA Mini Kit 
and eluded in 25 µL of elution buffer (TE). The quantity and the purity 
of the DNA in the samples were determined using the Nanodrop Thermo 
Scientific 1000 spectrophotometer. The samples were subsequently stored 
in a freezer at 20 oC for later use.
The polymerase chain reaction (PCR): In the PCR reaction, 
kDNA 20 (5’GGG KAG GGG CGT TCT SCG AA 3’) and kDNA 22 
(5’ SSS WCT ATW TTA CAC CAA CC CC3’) were used to target the 
amplification of the conserved region of kDNA mini circles of Leishmania 
sp, producing a fragment of 120 base pairs5. According to the amount of 
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DNA from the extracted material, volumes between 2 and 4 µL (100 ng) 
of sample were added to 20 µL of reaction buffer containing 50 mM 
of KCl, 10 mM of Tris-HCl (pH 8.0), 0.2 mM of dNTPs, 1.0 mM of 
MgCl2, 0.4 µM of each primer and one unit of Taq DNA polymerase 
(Fermentas, Canada). Two negative controls were employed containing 
all of the components of the reaction together with milli-Q water. The 
positive control was obtained from the culture material of the Leishmania 
infantum strain (reference M6445). Each reaction was performed at an 
initial denaturation temperature of 94 °C for five minutes followed by 
35 cycles of denaturation at 94 °C for one minute, annealing at 58 °C 
for one minute, extension at 72 °C for 30 seconds, and a final extension 
of 72 °C for five minutes. Reactions were performed in a thermocycler 
(Mini Cycler MJ Research/USA). PCR products were visualized on 2% 
agarose gel. Immediately after electrophoresis, the gel was stained with 
0.5 µg/mL of ethidium bromide. The amplified products were visualized 
by UV light over a transilluminator (AlphaImager) (Fig. 1).
CASE REPORT AND RESULTS
Herein, we report a case of a co-infected (HIV/VL) 32-year-old 
female, who was hospitalized six times over a period of one year and a 
half with clinical suspicion of VL reactivation.
The patient has had the HIV infection since she was 19 years old. The 
highly active antiretroviral therapy (HAART) has been used irregularly 
and the count of CD4+ T cell never exceeded 100 cells/mm3. The first 
diagnosis of VL was made in 2008.
In the patient’s first admission to the hospital, she clinically presented 
chills, fever, anorexia, and enlargement of liver and spleen. Leishmania 
was found in samples from smear examination of BM, and kDNA PCR 
was positive in the PB. She received liposomal amphotericin B, 4 mg/
kg/day for five days. At this time, the NNN/BHI culture medium from 
BM was negative. She was discharged without symptoms.
In a second hospitalization, six months later, the patient had fever and 
asthenia. Laboratory diagnosis of leishmaniasis was established through 
PB samples only; evaluation of smear and culture yielded negative results, 
but PCR turned out positive, allowing the patient to receive the same 
treatment as on the first admission. 
The patient was hospitalized a third time five months later due to 
fever, prostration, and dyspnea. Once more, using only PB samples, smear 
microscopy, culture examination, and kDNA PCR were carried out. Again, 
only the kDNA PCR yielded positive results. This led to a diagnosis of 
reactivation and the patient underwent an additional treatment. 
Yet another time, five months later, the patient was hospitalized 
with symptoms of headache, fever, liver and spleen enlargement, 
and pancytopenia. Samples of BM and PB were obtained to perform 
microscopic examination of smear, culture, and kDNA PCR. The smear 
from PB only suggested the presence of amastigotes; the culture was 
negative. Once again, because of the positivity of kDNA, the patient 
was treated. One month later, the patient was admitted to the hospital 
once more, this time due to anemia and again to pancytopenia. In the 
culture of BM aspirate, promastigotes were observed by microscopy. 
The microscopic examination of smear after panoptic staining revealed 
the presence of amastigotes. Only at this time PCR was not performed. 
Finally, in the patient’s last hospitalization two months later, positive 
results were obtained in samples of both BM and PB using kDNA PCR, 
and in BM alone using smear. The PB smear only suggested the presence 
of amastigotes; cultures were negative. The patient received the same 
treatment as before and was well when discharged.
DISCUSSION AND CONCLUSION
Leishmania/HIV co-infection emerges as a serious disease, 
demanding a fast diagnostic method for detecting active disease and 
relapse so as to enable prompt treatment. The patient herein reported 
had several predictors of recurrence, such as CD4+ cell count below 100 
cells/mL at the time of the primary diagnosis of VL, failure to recover the 
number of CD4+ lymphocytes after the first episode of VL, and previous 
episodes of failure4. Significantly, the patient was always a poor adherent 
to antiviral therapy. However, even patients who use HAART regularly 
and have a recovery of the CD4+ cell count and an undetectable viral 
load ,and who also receive secondary prophylaxis can suffer VL relapses.
Since co-infection favors a poor outcome, amastigotes can be found in 
PB1. Hence, it is possible to avoid invasive and painful techniques, such as 
bone marrow aspiration, by replacing them with others that use peripheral 
blood. The kDNA PCR assay can be a useful technique especially 
when PB is utilized. In a study comparing PCR with parasitological 
and serological techniques, PIARROUX et al. obtained a sensitivity 
of 82% for PCR7. In our report, kDNA PCR investigation produced 
positive results in all five molecular diagnoses in the patient’s total of six 
hospitalizations, suggesting the hypothesis of VL reactivation. Only once 
was PCR not performed. In three of her six hospital stays, when both 
BM and PB were investigated, PCR was always positive. In two of the 
six hospitalizations, only PB was examined, and only kDNA PCR was 
positive. Amastigotes were observed by microscopic smear examination 
four times, and in three of these, the sample was obtained from BM, 
necessarily using an invasive technique. On the sixth admission, the 
NNN/BHI culture medium was positive in a sample proceeding from 
BM. Considering these findings and our aim to apply a non-invasive 
technique for obtaining samples, in order to avoid unnecessary pain and 
to prevent time-consuming techniques and subjective test interpretations, 
it is a priority to improve molecular tools for monitoring patients who are 
liable to VL reactivation, which is usual in HIV/VL co-infected patients. 
It is important to emphasize that co-infected patients do not clear 
Leishmania DNA from peripheral blood nor can they show a rapid 
Fig. 1 - Detection of kDNA-120 bp amplification in the sample from bone marrow (BM) and 
peripheral blood (PB) of the patient with LV.
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reappearance of Leishmania DNA after therapy and these situations can 
or cannot be associated with clinical disease.
A negative result is strongly indicative of successful control of 
infection and efficacy of treatment, whereas a positive PCR result could 
be indicative only of the presence of the parasite, but not necessarily 
of relapse during an asymptomatic period8. Therefore, qualitative PCR 
testing positive in the absence of clinical symptoms of the disease is not 
always related to VL reactivation in co-infected patients.
The kDNA PCR seems to be a useful tool for diagnosing VL, and 
it may be a good marker for predicting VL relapses after treatment in 
co-infected patients with clinical symptoms of the disease.
RESUMO
Utilidade da kDNA PCR no diagnóstico de reativação de 
leishmaniose visceral em pacientes co-infectados sintomáticos
É importante a pesquisa de novos métodos laboratoriais para o 
diagnóstico de recidivas em casos de co-infecção leishmaniose visceral 
(LV) e vírus da imunodeficiência humana (HIV), que permitam o 
diagnóstico precoce das recidivas, utilizando métodos menos invasivos. 
Descrevemos aqui, o caso de paciente co-infectada que apresentou 
recidivas após o tratamento da LV e onde a PCR qualitativa demonstrou 
bom desempenho. A kDNA PCR parece ser ferramenta útil para o 
diagnóstico de recidivas de LV após o tratamento em pacientes co-
infectados com sintomas clínicos da doença.
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